Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Breast Cancer Research and Treatment|December 22, 2014
Biological and clinical significance of PARP1 protein expression in breast cancerAndrew R Green, Daniela Caracappa, Ahmed A Benhasouna, et al.Breast Cancer Research and Treatment|August 25, 2009
PIK3CA expression in invasive breast cancer: a biomarker of poor prognosisMohammed A Aleskandarany, Emad A Rakha, Mohamed A H Ahmed, et al.Eplasty|September 15, 2012
A position statement on optimizing the role of oncoplastic breast surgeryChristoph Andree, Jian Farhadi, Dennis Goossens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancerSahar M A Mahmoud, Emma Claire Paish, Desmond G Powe, et al.Breast Cancer Research and Treatment|September 29, 2007
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcomeAndrew R Green, Claire Burney, Christopher J Granger, et al.British Journal of Cancer|September 17, 2020
Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situIslam M Miligy, Michael S Toss, Sho Shiino, et al.British Journal of Cancer|August 11, 2020
The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situIslam M Miligy, Michael S Toss, Sho Shiino, et al.International Journal of Cancer|August 28, 2009
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancerMohammed A Aleskandarany, Andrew R Green, Emad A Rakha, et al.British Journal of Cancer|March 9, 2016
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumoursAndrew R Green, Mohammed A Aleskandarany, Devika Agarwal, et al.Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.Pageof 4